Invention Grant
- Patent Title: Furazanobenzimidazoles
- Patent Title (中): 呋喃并苯并咪唑
-
Application No.: US10557539Application Date: 2004-05-19
-
Publication No.: US07385061B2Publication Date: 2008-06-10
- Inventor: Martin Eberle , Felix Bachmann , Alessandro Strebel , Subho Roy , Sudhir Srivastava , Goutam Saha
- Applicant: Martin Eberle , Felix Bachmann , Alessandro Strebel , Subho Roy , Sudhir Srivastava , Goutam Saha
- Applicant Address: CH Basel
- Assignee: Basilea Pharmaceutica AG
- Current Assignee: Basilea Pharmaceutica AG
- Current Assignee Address: CH Basel
- Priority: EP03405365 20030523
- International Application: PCT/IB2004/001723 WO 20040519
- International Announcement: WO2004/103994 WO 20041202
- Main IPC: A61K31/4245
- IPC: A61K31/4245 ; C07D413/04

Abstract:
The invention relates to compounds of formula (I) wherein R represents aryl or heteroaryl, X is oxygen, a carbonyl group, an oxime derivative of a carbonyl group or an α,β-unsaturated carbonyl group, and the substituents R1 to R6 have the meanings given in the specification, for use as medicaments, to novel compounds of formula (I), to methods of synthesis of such compounds, to pharmaceutical compositions containing compounds of formula (I), to the use of a compounds of formula (I) for the preparation of a pharmaceutical composition for the treatment of neoplastic and autoimmune diseases, and to methods of treatment of neoplastic and autoimmune diseases using such compounds of formula (I) or of pharmaceutical compositions containing same
Public/Granted literature
- US20070043061A1 Furazanobenzimidazoles Public/Granted day:2007-02-22
Information query